Task: Answer the multiple-choice question.
Question: Which drug exhibits a 6.548% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
[a] Cn1ccnc1SCC(=O)Nc1nc2c(F)c(F)c(F)cc2s1
[b] Cc1nc(SCC(=O)NCCc2ccccc2)nc(C)c1C
[c] CN(C)S(=O)(=O)c1ccc(NC(=O)c2ccncc2)cc1
[d] Cn1c(=O)[nH]c(=O)c2c1nc(NCCc1ccccc1)n2CC(O)COc1ccccc1
Answer: b. Cc1nc(SCC(=O)NCCc2ccccc2)nc(C)c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc(SCC(=O)NCCc2ccccc2)nc(C)c1C
Cc1nc(SCC(=O)NCCc2ccccc2)nc(C)c1C
N-(2-phenylethyl)-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylacetamide